Post-COVID Apheresis Register

If you are interested in participating, please send an email to info@e-isfa.eu. You will then receive all information and documents.

Why the register?

As a specialist society, E-ISFA works to strengthen therapeutic apheresis (TA) and improve its underlying scientific basis. Following the first reports of successful TA treatments in patients with so-called Post-COVID Syndrome, we set out to build a data basis that allows a sound assessment of the possible benefits and risks of apheresis treatment.

Who can participate?

Participation is open to all physicians who carry out corresponding treatments using TA procedures. Requirements include a signed centre agreement with E-ISFA and a positive vote from the responsible ethics committee.

Ethics vote

For this register, including the sample collection, a positive assessment by the lead ethics committee of the Landesärztekammer Baden-Württemberg has been in place since 6 September 2022.

Funding and sponsors

The Post-COVID Apheresis Register was developed and financed by E-ISFA. BioArtProducts GmbH, Rostock, is responsible for implementation and IT management.